Kerala government decides to treat under 18 haemophilia patients with Emicizumab
Health
By South First Desk
Jul 26, 2024
Read the article
The Kerala government said on Friday, 26 July, that it has decided to use the drug Emicizumab to treat all children below the age of 18 having the disorder.
Read the article
Health
Around 300 children are expected to benefit from this.
Read the article
Health
Haemophilia — also known as the royal disease — is a usually inherited bleeding disorder that prevents the blood from clotting properly.
Read the article
Health
Emicizumab is a medication used to prevent bleeding episodes in people with haemophilia.
Read the article
Health
It’s a bio-specific antibody that helps blood to clot normally, reducing the risk of bleeding complications.
Read the article
Health
Kerala has around 2000 haemophilia patients registered under the Ashadhara programme.
Read the article
Health
Haemophilia A occurs due to low amounts of clotting factor VIII and haemophilia B occurs due to low levels of clotting factor IX .
Read the article
Health